ESR1 and complete blood cell count: MBC shares some similarities with post-menopausal estrogen receptor (ER)-positive female breast cancer (FBC), however increasing evidence indicates that, on clinical and molecular level, MBC may be a heterogeneous disease, different from FBC [4–6].